Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Jean Marc Bigourdan is a leading figure in the advancement of minimally invasive pancreatic surgery, with a focused expertise in left pancreatectomy. His primary research area centers on improving surgical outcomes by analyzing the critical factors that lead to conversion from minimally invasive to open procedures. Dr. Bigourdan’s major contribution is the development of a predictive Conversion Risk Score (CRS), a practical tool designed to help surgeons identify high-risk patients preoperatively, thereby enhancing surgical planning and patient counseling. His seminal 2025 work on this topic, which has already garnered 4 citations, demonstrates his impact by systematically identifying risk factors for conversion and, crucially, establishing a strong association between conversion and severe postoperative complications. This research directly addresses a core challenge in the field, where conversion occurs in 15-30% of cases. By providing a validated risk stratification method, Dr. Bigourdan is helping to refine patient selection and reduce morbidity, marking him as a key contributor to safer, more effective minimally invasive surgical techniques.